e-learning
resources
ERJ
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment failure in tuberculosis
Panickar J. R., Hoskyns W.
Source:
Eur Respir J 2007; 29: 561-564
Journal Issue:
March
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Panickar J. R., Hoskyns W.. Treatment failure in tuberculosis. Eur Respir J 2007; 29: 561-564
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Latent tuberculosis infection as a cause of tuberculosis disease
Source: Eur Respir J 2003; 22: Suppl. 45, 157s
Year: 2003
Diagnosis and treatment of latent tuberculosis infection
Source: Eur Respir Monogr 2018; 82: 381-398
Year: 2018
Treatment of latent infection with Mycobacterium tuberculosis: update 2010
Source: Eur Respir J 2011; 37: 690-711
Year: 2011
Latent tuberculosis infection in a drug treatment centre
Source: Eur Respir J 2002; 20: Suppl. 38, 366s
Year: 2002
Diagnosis of latent tuberculosis infection
Source: ERS Live 2007
Year: 2007
Latent tuberculosis infection in children in contact with pulmonary tuberculosis patients
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
MOTT as a cause of treatment failure in pulmonary tuberculosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
Completion of treatment for latent tuberculosis infection
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction
Source: Eur Respir Rev 2009; 18: 295-299
Year: 2009
Causes of therapeutical failure in tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 42s
Year: 2003
Clinical management of tuberculosis and HIV-1 co-infection
Source: Eur Respir J 2010; 36: 1460-1481
Year: 2010
Acute renal failure due to rifampicin during tuberculosis treatment
Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis
Year: 2007
Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011
How should we treat latent tuberculosis infection?
Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches
Year: 2003
Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 339s
Year: 2001
Treatment of latent tuberculosis infection with 6 months isoniazid therapy in pediatric population
Source: Eur Respir J 2005; 26: Suppl. 49, 624s
Year: 2005
Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease
Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept